- Report
- October 2024
- 195 Pages
Global
From €3244EUR$3,545USD£2,819GBP
€3605EUR$3,939USD£3,132GBP
- Report
- February 2025
- 150 Pages
Global
From €4438EUR$4,850USD£3,856GBP
- Report
- February 2025
- 200 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- April 2025
- 200 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- March 2025
- 200 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- February 2024
- 202 Pages
Global
From €4576EUR$5,000USD£3,976GBP
- Report
- October 2022
- 194 Pages
Global
From €4576EUR$5,000USD£3,976GBP
- Report
- November 2020
- 217 Pages
Global
From €3660EUR$4,000USD£3,180GBP
- Report
- January 2023
- 170 Pages
China
From €2279EUR$2,490USD£1,980GBP
- Report
- September 2024
- 82 Pages
Japan
From €3203EUR$3,500USD£2,783GBP
- Report
- March 2024
- 250 Pages
Global
From €3294EUR$3,600USD£2,862GBP
- Report
- March 2024
- 119 Pages
Europe
From €1373EUR$1,500USD£1,193GBP
- Report
- March 2024
- 119 Pages
Asia Pacific
From €1373EUR$1,500USD£1,193GBP
- Report
- March 2024
- 106 Pages
North America
From €1373EUR$1,500USD£1,193GBP
- Report
- March 2024
- 120 Pages
Middle East, Africa
From €1373EUR$1,500USD£1,193GBP
- Report
- July 2024
- 326 Pages
China
From €3660EUR$4,000USD£3,180GBP
- Report
- July 2024
- 187 Pages
China
From €1647EUR$1,800USD£1,431GBP
- Report
- July 2020
- 213 Pages
Global, China
From €2928EUR$3,200USD£2,544GBP
- Report
- January 2024
- 95 Pages
Global
From €3500EUR$4,097USD£3,147GBP
- Report
- March 2024
- 74 Pages
Global
From €3500EUR$4,097USD£3,147GBP

The Rabies Vaccine market is a subset of the Vaccines market, which is a global industry that produces and distributes immunizations to protect against infectious diseases. Rabies Vaccines are used to protect against the rabies virus, which is a fatal disease that is spread through the saliva of infected animals. The Rabies Vaccine market is composed of a variety of products, including pre-exposure and post-exposure vaccines, as well as combination vaccines. These products are used in both humans and animals, and are typically administered by injection.
The Rabies Vaccine market is highly regulated, with stringent safety and efficacy standards in place to ensure the quality of the products. Additionally, the market is subject to a variety of government regulations, including those related to pricing and distribution.
Some companies in the Rabies Vaccine market include Merck & Co., Inc., Sanofi Pasteur, GlaxoSmithKline, and Pfizer, Inc. Show Less Read more